180 related articles for article (PubMed ID: 26280818)
1. Lipid nanocapsules as a new delivery system in copepods: Toxicity studies and optical imaging.
Stancheva S; Souissi A; Ibrahim A; Barras A; Spriet C; Souissi S; Boukherroub R
Colloids Surf B Biointerfaces; 2015 Nov; 135():441-447. PubMed ID: 26280818
[TBL] [Abstract][Full Text] [Related]
2. Lipid nanocapsules for behavioural testing in aquatic toxicology: Time-response of Eurytemora affinis to environmental concentrations of PAHs and PCB.
Michalec FG; Holzner M; Souissi A; Stancheva S; Barras A; Boukherroub R; Souissi S
Aquat Toxicol; 2016 Jan; 170():310-322. PubMed ID: 26362585
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanocapsules functionalized with polyethyleneimine for plasmid DNA and drug co-delivery and cell imaging.
Skandrani N; Barras A; Legrand D; Gharbi T; Boulahdour H; Boukherroub R
Nanoscale; 2014 Jul; 6(13):7379-90. PubMed ID: 24871584
[TBL] [Abstract][Full Text] [Related]
4. Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications.
Formica ML; Ullio Gamboa GV; Tártara LI; Luna JD; Benoit JP; Palma SD
Int J Pharm; 2020 Jan; 573():118795. PubMed ID: 31682964
[TBL] [Abstract][Full Text] [Related]
5. Ecotoxicological investigation of the effect of accumulation of PAH and possible impact of dispersant in resting high arctic copepod Calanus hyperboreus.
Nørregaard RD; Gustavson K; Møller EF; Strand J; Tairova Z; Mosbech A
Aquat Toxicol; 2015 Oct; 167():1-11. PubMed ID: 26253790
[TBL] [Abstract][Full Text] [Related]
6. Effects of selected PAHs on reproduction and survival of the calanoid copepod Acartia tonsa.
Bellas J; Thor P
Ecotoxicology; 2007 Aug; 16(6):465-74. PubMed ID: 17562161
[TBL] [Abstract][Full Text] [Related]
7. Predicting single and mixture toxicity of petrogenic polycyclic aromatic hydrocarbons to the copepod Oithona davisae.
Barata C; Calbet A; Saiz E; Ortiz L; Bayona JM
Environ Toxicol Chem; 2005 Nov; 24(11):2992-9. PubMed ID: 16398138
[TBL] [Abstract][Full Text] [Related]
8. Sorption of PAHs to microplastic and their bioavailability and toxicity to marine copepods under co-exposure conditions.
Sørensen L; Rogers E; Altin D; Salaberria I; Booth AM
Environ Pollut; 2020 Mar; 258():113844. PubMed ID: 31874435
[TBL] [Abstract][Full Text] [Related]
9. Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins.
Lorenzoni R; Cordenonsi LM; Davies S; Antonow MB; Medina Diedrich AS; Santos CG; Vitalis GS; Garrastazu G; Buttini F; Sonvico F; Gomes P; Raffin RP
J Microencapsul; 2019 Jun; 36(4):317-326. PubMed ID: 31159613
[No Abstract] [Full Text] [Related]
10. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
11. Absence of lung fibrosis after a single pulmonary delivery of lipid nanocapsules in rats.
Hureaux J; Lacoeuille F; Lagarce F; Rousselet MC; Contini A; Saulnier P; Benoit JP; Urban T
Int J Nanomedicine; 2017; 12():8159-8170. PubMed ID: 29184405
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.
Zhao YQ; Wang LP; Ma C; Zhao K; Liu Y; Feng NP
Int J Nanomedicine; 2013; 8():4169-81. PubMed ID: 24204145
[TBL] [Abstract][Full Text] [Related]
14. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application.
Yadava SK; Basu SM; Chauhan M; Sharma K; Pradhan A; V R; Giri J
Colloids Surf B Biointerfaces; 2020 Jun; 190():110927. PubMed ID: 32169777
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
[TBL] [Abstract][Full Text] [Related]
16. Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery.
Urimi D; Widenbring R; Pérez García RO; Gedda L; Edwards K; Loftsson T; Schipper N
Int J Pharm; 2021 Jun; 602():120640. PubMed ID: 33901599
[TBL] [Abstract][Full Text] [Related]
17. Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery.
Groo AC; Saulnier P; Gimel JC; Gravier J; Ailhas C; Benoit JP; Lagarce F
Int J Nanomedicine; 2013; 8():4291-302. PubMed ID: 24235827
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity and genotoxicity of lipid nanocapsules.
Le Roux G; Moche H; Nieto A; Benoit JP; Nesslany F; Lagarce F
Toxicol In Vitro; 2017 Jun; 41():189-199. PubMed ID: 28323104
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor efficacy of paclitaxel with PEGylated lipidic nanocapsules in presence of curcumin and poloxamer: In vitro and in vivo studies.
Anwar M; Akhter S; Mallick N; Mohapatra S; Zafar S; Rizvi MMA; Ali A; Ahmad FJ
Pharmacol Res; 2016 Nov; 113(Pt A):146-165. PubMed ID: 27546165
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration.
Roger E; Lagarce F; Benoit JP
Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
